In autoimmune diseases, such as systemic lupus erythematosus and rheumatoid arthritis, SHIP1 functions as a critical negative regulator of TLR3-mediated IFN-β production through affecting the localization and activity of TBK1 (52). Here, TBK1 is linked to systemic lupus erythematosus.